Hamed-Azzam Shirin, Burkat Cat, Mukari Abed, Briscoe Daniel, Joshi Narish, Scawn Richard, Alon Eran, Hartstein Morris
Baruch Padeh Medical Center, Poriya, Israel.
University of Wisconsin, Madison, WI, USA.
Aesthet Surg J. 2021 May 18;41(6):NP559-NP566. doi: 10.1093/asj/sjaa264.
Dermal filler injections continue to grow in popularity as a method of facial rejuvenation. This increase in the number of injections performed has resulted in an increasing number of types of filler-related complications.
We report a series of cases where dermal filler injected in the face migrated to the orbit. Treatment methods and possible mechanisms of this newly reported complication are discussed.
A retrospective, multicenter analysis was performed on patients with dermal filler migration to the orbit after facial filler injections.
Seven patients (6 females, 1 male; age range, 42-67 years) presented with orbital symptoms after filler injection and were subsequently found to have dermal filler in the orbit. Four out of 7 patients underwent orbitotomy surgery, 1 patient underwent lacrimal surgery, 1 patient had strabismus surgery, and 1 patient was treated with hyalurodinase injections. All patients have remained stable postoperatively.
Orbital complications secondary to migrated filler may occur long after the initial procedure. Because the site of the complication is distant from the injection site, patients and physicians may not immediately make the connection. Furthermore, this may lead to unnecessary examinations and a delay in diagnosis while looking for standard orbital masses. Dermal fillers should therefore be considered in the differential diagnosis of patients presenting with new-onset orbital masses.
作为一种面部年轻化方法,注射填充剂越来越受欢迎。注射量的增加导致了越来越多与填充剂相关的并发症类型。
我们报告了一系列面部注射填充剂后迁移至眼眶的病例。讨论了这种新报道并发症的治疗方法和可能机制。
对面部填充剂注射后填充剂迁移至眼眶的患者进行回顾性多中心分析。
7例患者(6例女性,1例男性;年龄范围42 - 67岁)在填充剂注射后出现眼眶症状,随后发现眼眶内有填充剂。7例患者中,4例接受了眼眶切开术,1例接受了泪道手术,1例接受了斜视手术,1例接受了透明质酸酶注射治疗。所有患者术后情况稳定。
填充剂迁移继发的眼眶并发症可能在初始操作后很长时间才出现。由于并发症部位与注射部位距离较远,患者和医生可能不会立即建立联系。此外,在寻找标准眼眶肿物时,这可能导致不必要的检查和诊断延迟。因此,在鉴别诊断新发眼眶肿物患者时应考虑填充剂因素。